摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-amino-1-((4aR,6R,7aR)-7,7-difluoro-2-(((4RS,5RS)-5-(2-(2-(2-methoxyethoxyl)ethoxy)ethoxy)-1,2-dithian-4-yl)oxy)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)pyrimidin-2(1H)-one

中文名称
——
中文别名
——
英文名称
4-amino-1-((4aR,6R,7aR)-7,7-difluoro-2-(((4RS,5RS)-5-(2-(2-(2-methoxyethoxyl)ethoxy)ethoxy)-1,2-dithian-4-yl)oxy)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)pyrimidin-2(1H)-one
英文别名
1-[(4aR,6R,7aR)-7,7-difluoro-2-[(4R,5R)-5-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]dithian-4-yl]oxy-2-oxo-4,4a,6,7a-tetrahydrofuro[3,2-d][1,3,2]dioxaphosphinin-6-yl]-4-aminopyrimidin-2-one
4-amino-1-((4aR,6R,7aR)-7,7-difluoro-2-(((4RS,5RS)-5-(2-(2-(2-methoxyethoxyl)ethoxy)ethoxy)-1,2-dithian-4-yl)oxy)-2-oxidotetrahydro-4H-furo[3,2-d][1,3,2]dioxaphosphinin-6-yl)pyrimidin-2(1H)-one化学式
CAS
——
化学式
C20H30F2N3O10PS2
mdl
——
分子量
605.575
InChiKey
UFEITBGLZIXLFV-RYVBYCDVSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.5
  • 重原子数:
    38
  • 可旋转键数:
    13
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    200
  • 氢给体数:
    1
  • 氢受体数:
    14

文献信息

  • NUCLEOSIDE KINASE BYPASS COMPOSITIONS AND METHODS
    申请人:MERCK SHARP & DOHME CORP.
    公开号:US20150315221A1
    公开(公告)日:2015-11-05
    The present invention relates to disulfide masked prodrug compounds, compositions and methods that are amenable to bioactivation by a reducing agent such as glutathione. Such disulfide based compounds, compositions, and methods can be useful, for example, in providing novel prodrugs for use as therapeutics.
    本发明涉及一种二硫化物掩蔽的前药化合物、组合物和方法,这些化合物、组合物和方法可通过还原剂如谷胱甘肽进行生物活化。这种基于二硫化物的化合物、组合物和方法可以用于提供新型前药,例如用作治疗药物。
  • US9624249B2
    申请人:——
    公开号:US9624249B2
    公开(公告)日:2017-04-18
  • [EN] NUCLEOSIDE KINASE BYPASS COMPOSITIONS AND METHODS<br/>[FR] COMPOSITIONS ET MÉTHODES DE DÉRIVATION DE KINASES NUCLÉOSIDIQUES
    申请人:MERCK SHARP & DOHME
    公开号:WO2014088923A1
    公开(公告)日:2014-06-12
    The present invention relates to disulfide masked prodrug compounds, compositions and methods that are amenable to bioactivation by a reducing agent such as glutathione. Such disulfide based compounds, compositions, and methods can be useful, for example, in providing novel prodrugs for use as therapeutics. The compounds feature a conformationally restricted disulfide phosphotriester moiety to mask anionic charge. The compounds include a 1,2-dithigne moiety.
查看更多